|
| |
Omeprazole OTC Effects, Dosage, and Side Effects trials
|
(e.g. Acne, Diabetes, Acupuncture, Homeopathy, etc.)
| |  | |
|
|
Get Your Free Credit Report Right Now!
|
|
Omeprazole OTC
|
|
Prilosec OTC
|
Omeprazole OTC Clinical Trials
- Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
ClinicalTrials.gov Identifier: NCT00226044 - Recruiting
Gastroesophageal Reflux; Esophageal Atresia; Hernia, Diaphragmatic
- Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
ClinicalTrials.gov Identifier: NCT00141102 - Recruiting
Osteoarthritis; Arthritis, Rheumatoid
- Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
Gastric Cancer; Precancerous Condition
- A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects
ClinicalTrials.gov Identifier: NCT00251030 - Completed
- Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel
ClinicalTrials.gov Identifier: NCT00349661 - Recruiting
Coronary Heart Disease
- Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.
ClinicalTrials.gov Identifier: NCT00298779 - Active, not recruiting
Tumors; Non-Hodgkins's Lymphoma
- Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies
ClinicalTrials.gov Identifier: NCT00420615 - Recruiting
Solid Tumors
- An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00442208 - Active, not recruiting
Healthy
- Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation
ClinicalTrials.gov Identifier: NCT00426595 - Recruiting
Gastreoesophageal Reflux Disease
- Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
- Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-Adjusted Dosing
ClinicalTrials.gov Identifier: NCT00537732 - Recruiting
Gastroesophageal Reflux
- Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding
ClinicalTrials.gov Identifier: NCT00402259 - Recruiting
Gastrointestinal Hemorrhage
- Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
stage I gastric cancer
- A Prospective Randomized Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer
ClinicalTrials.gov Identifier: NCT00164931 - Recruiting
Peptic Ulcer Hemorrhage
- Does Omeprazole Decrease Intestinal Calcium Absorption?
ClinicalTrials.gov Identifier: NCT00582972 - Not yet recruiting
Osteoporosis; Achlorhydria; GERD; Hip Fracture
- Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
Gastroparesis; Gastroesophageal Reflux Disease
- Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
ClinicalTrials.gov Identifier: NCT00542347 - Recruiting
Gastric Acid
- The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients with Hypersecretion of Gastric Acid
ClinicalTrials.gov Identifier: NCT00001191 - Completed
Gastrinoma; Zollinger Ellison Syndrome
- Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
ClinicalTrials.gov Identifier: NCT00045799 - Completed
Upper gastrointestinal bleeding
- Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers
ClinicalTrials.gov Identifier: NCT00519519 - Recruiting
Bleeding Peptic Ulcers Disease
- Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
ClinicalTrials.gov Identifier: NCT00002682 - Active, not recruiting
mucosa-associated lymphoid tissue; stage I diffuse small lymphocytic/marginal zone lymphoma
- A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches - 1
ClinicalTrials.gov Identifier: NCT00134927 - Active, not recruiting
Tobacco Use Disorder; nicotine
- Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
ClinicalTrials.gov Identifier: NCT00003151 - Active, not recruiting
contiguous stage II diffuse small lymphocytic/marginal zone lymphoma; stage I diffuse small lymphocytic/marginal zone lymphoma
- Sopran - Omeprazole Treatment Versus Surgery
ClinicalTrials.gov Identifier: NCT00256737 - Completed
GERD
- Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-Positive Gastric Ulcer After Eradication Therapy
ClinicalTrials.gov Identifier: NCT00272467 - Completed
Stomach Ulcer
- A Study to Investigate the Pharmacodynamic Effect After Four-Week Omeprazole Treatment of Non-Erosive Reflux Disease in a Japanese Population
ClinicalTrials.gov Identifier: NCT00259051 - Completed
Non-Erosive Reflux Disease
- Four-Week Omeprazole Treatment of Non-Erosive Reflux Disease in a Japanese Population
ClinicalTrials.gov Identifier: NCT00259077 - Completed
Non-Erosive Reflux Disease
- Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)
ClinicalTrials.gov Identifier: NCT00442741 - Terminated
Solid Tumors
- A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination with Omeprazole Given Orally in Patients with Symptoms of Symptomatic Gastroespohageal Reflux Disease (sGERD)
ClinicalTrials.gov Identifier: NCT00149851 - Completed
symptomatic gastroespohageal reflux disease
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
|
Take control over your directory listings...INSTANTLY
Every day, thousands of users find businesses like yours in the GoldBamboo directory.
Limited Time Offer!!!
For only $30 a year, a savings of 70% off our standard rate:
- Edit your listing (whenever you want!)
- Link to your website
- Choose which categories you are listed in
- Describe your services
The process will take only a few minutes and consists of 3 easy steps:
1. Register
>
2. Edit Listings
>
3. Publish
Your Company
your street
yourtown, YS 12345
888-888-8888
No Thanks
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is
provided for educational purposes only. Consult a physician regarding
the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.
Home |
About Us |
Link To Us |
Feedback |
Disclaimer |
Privacy Policy |
Terms of Use |
Health Forums
Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.
 |
| We comply with the HONcode standard for health trust worthy information:
verify here.
|
|
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page